Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
AVAvalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN)

NASDAQ Global Market · Currency in USD
$26.04 ▼ -1.21 (-4.44%)
At close: Oct 23, 4:00 PM ET. Market closed.
$26.55 ▲ +0.51 (+1.96%)
After hours: Oct 23, 6:36 PM ET

Summary

Previous Close
$27.25
Open
$27.21
Day's Range
$25.44 – $27.21
52 Week Range
$22.24 – $40.17
Volume
320,312
Avg. Volume
312,025
Market Cap
$1.15B
Beta (5Y Monthly)
-1.13
PE Ratio (TTM)
--
EPS (TTM)
-$1.26
Earnings Date
Nov 11, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$60.00

Profile: Avalyn Pharma Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
55
CEO
Lyn Baranowski

Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W.

Earnings

Next report: Wed, Nov 11, 2026
EPS estimate -$0.71
DateEst.Actual
Aug 12, 2026-$0.78-$0.98Miss
Jun 3, 2026-$5.98-$21.83Miss

Analyst view

Consensus price target
$60.00 ▲ +130.4%
Range $51.00 – $80.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on AVLN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.